Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Seungmin, Ham"'
Autor:
Emanuela Talamonti, Jelena Davegardh, Anastasia Kalinovich, Sten M.M. van Beek, Nodi Dehvari, Carina Halleskog, Hamza M. Bokhari, Dana S. Hutchinson, Seungmin Ham, Laura J. Humphrys, Nicola C. Dijon, Aikaterini Motso, Anna Sandstrom, Evelyn Zacharewicz, Ilga Mutule, Edgars Suna, Jana Spura, Karolina Ditrychova, Leigh A. Stoddart, Nicholas D. Holliday, Shane C. Wright, Volker M. Lauschke, Soren Nielsen, Camilla Scheele, Elizabeth Cheesman, Joris Hoeks, Peter Molenaar, Roger J. Summers, Benjamin Pelcman, Gopala K. Yakala, Tore Bengtsson
Publikováno v:
Molecular Metabolism, Vol 85, Iss , Pp 101931- (2024)
Objective: Simultaneous activation of β2- and β3-adrenoceptors (ARs) improves whole-body metabolism via beneficial effects in skeletal muscle and brown adipose tissue (BAT). Nevertheless, high-efficacy agonists simultaneously targeting these recept
Externí odkaz:
https://doaj.org/article/3d4a3a5490234ea7a397025d54414624
Autor:
Seungmin Ham, Saori Mukaida, Masaaki Sato, Peter Keov, Tore Bengtsson, Sebastian Furness, Nicholas D. Holliday, Bronwyn A. Evans, Roger J. Summers, Dana S. Hutchinson
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 1, Pp n/a-n/a (2024)
Abstract Truncation of the C‐terminal tail of the β2‐AR, transfection of βARKct or over‐expression of a kinase‐dead GRK mutant reduces isoprenaline‐stimulated glucose uptake, indicating that GRK is important for this response. We explored
Externí odkaz:
https://doaj.org/article/8b05f72e8cfe40dba5549ad1377f554f
Publikováno v:
Archives of Clinical and Medical Case Reports.
Autor:
Navista Sri Octa, Ujiantari, Seungmin, Ham, Chisae, Nagiri, Wataru, Shihoya, Osamu, Nureki, Dana Sabine, Hutchinson, Daniela, Schuster
Publikováno v:
Molecular informatics. 41(7)
The β
Autor:
Seungmin Ham, Eric Vilain, Vincent R. Harley, Joohyung Lee, Paulo Pinares-Garcia, Hannah Loke
Publikováno v:
Proceedings of the National Academy of Sciences. 116:16577-16582
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder caused by the loss of midbrain dopamine (DA) neurons. While the cause of DA cell loss in PD is unknown, male sex is a strong risk factor. Aside from the protective actions of sex
Autor:
Navista Sri Octa Ujiantari, Seungmin Ham, Chisae Nagiri, Wataru Shihoya, Osamu Nureki, Dana Sabine Hutchinson, Daniela Schuster
Publikováno v:
Molecular Informatics. 41:2100223
Autor:
Helen B Forrester, Peter Temple-Smith, Seungmin Ham, David de Kretser, Graeme Southwick, Carl N Sprung
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59056 (2013)
Dupuytren's disease (DD) is a classic example of pathological fibrosis which results in a debilitating disorder affecting a large sector of the human population. It is characterized by excessive local proliferation of fibroblasts and over-production
Externí odkaz:
https://doaj.org/article/6b7ddbeab9384750af47ddf09ab37e1a
Autor:
Peter Temple-Smith, Seungmin Ham, Craig A. Harrison, Graeme Southwick, David M. de Kretser, Euan M. Wallace
Publikováno v:
Experimental dermatologyREFERENCES. 30(3)
Keloids are benign tumours caused by abnormal wound healing driven by increased expression of cytokines, including activin A. This study compared effects of activins on normal and keloid-derived human dermal fibroblasts and investigated a novel treat
Autor:
Masaaki Sato, Lynda Whiting, Dana S. Hutchinson, Seungmin Ham, Denise Wootten, Tore Bengtsson, Anastasia V. Kalinovich, Ling Yeong Chia, Saori Mukaida, Bronwyn A Evans, Nodi Dehvari, Jon Merlin, Huong T. M. Nguyen, Muhammad Hamza Bokhari, Roger J. Summers, Jie Gao
Publikováno v:
Pharmacology Research & Perspectives. 8
The β3 -adrenoceptor agonist mirabegron is approved for use for overactive bladder and has been purported to be useful in the treatment of obesity-related metabolic diseases in humans, including those involving disturbances of glucose homeostasis. W
Autor:
Nodi, Dehvari, Masaaki, Sato, Muhammad Hamza, Bokhari, Anastasia, Kalinovich, Seungmin, Ham, Jie, Gao, Huong T M, Nguyen, Lynda, Whiting, Saori, Mukaida, Jon, Merlin, Ling Yeong, Chia, Denise, Wootten, Roger J, Summers, Bronwyn A, Evans, Tore, Bengtsson, Dana S, Hutchinson
Publikováno v:
Pharmacology Research & Perspectives
The β3‐adrenoceptor agonist mirabegron is approved for use for overactive bladder and has been purported to be useful in the treatment of obesity‐related metabolic diseases in humans, including those involving disturbances of glucose homeostasis